These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 25699406)

  • 1. Predicting the Development of Tuberculosis with the Tuberculin Skin Test and QuantiFERON Testing.
    Altet N; Dominguez J; Souza-Galvão ML; Jiménez-Fuentes MÁ; Milà C; Solsona J; Soriano-Arandés A; Latorre I; Lara E; Cantos A; Ferrer MD; Orcau À; Ruiz-Manzano J; Caylà J
    Ann Am Thorac Soc; 2015 May; 12(5):680-8. PubMed ID: 25699406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
    Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.
    Zellweger JP; Sotgiu G; Block M; Dore S; Altet N; Blunschi R; Bogyi M; Bothamley G; Bothe C; Codecasa L; Costa P; Dominguez J; Duarte R; Fløe A; Fresard I; García-García JM; Goletti D; Halm P; Hellwig D; Henninger E; Heykes-Uden H; Horn L; Kruczak K; Latorre I; Pache G; Rath H; Ringshausen FC; Ruiz AS; Solovic I; Souza-Galvão ML; Widmer U; Witte P; Lange C;
    Am J Respir Crit Care Med; 2015 May; 191(10):1176-84. PubMed ID: 25763458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing contact tracing for tuberculosis in Kyrgyz Republic and risk factors for positivity using QuantiFERON-TB Gold plus.
    Corbett C; Kulzhabaeva A; Toichkina T; Kalmambetova G; Ahmedov S; Antonenka U; Iskakova A; Kosimova D; Migunov D; Myrzaliev B; Sahalchyk E; Umetalieva N; Vogel M; Kadyrov A; Hoffmann H
    BMC Infect Dis; 2020 Oct; 20(1):746. PubMed ID: 33046016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma release assays and tuberculin skin testing for diagnosing latent Mycobacterium tuberculosis infection in at-risk groups in Poland.
    Kruczak K; Mastalerz L; Sładek K
    Int J Mycobacteriol; 2016 Mar; 5(1):27-33. PubMed ID: 26927987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of QuantiFERON TB gold test compared with the tuberculin skin test for detecting latent tuberculosis infection in lung and heart transplant candidates.
    Mardani M; Farshidpour M; Nekoonam M; Varahram F; Najafizadeh K; Mohammadi N; Sharifkashani B; Gachkar L; Farokhzad B; Droudinia A; Javanmard P; Tabarsi P
    Exp Clin Transplant; 2014 Apr; 12(2):129-32. PubMed ID: 24702145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
    Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
    Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
    Matsumoto T; Yamazaki T
    Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
    Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
    Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the QuantiFERON®-TB Gold in Tube test for screening TB contacts and predictive value for active TB.
    Yoshiyama T; Harada N; Higuchi K; Saitou M; Kato S
    Infect Dis (Lond); 2015 Aug; 47(8):542-9. PubMed ID: 25901728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study.
    Basu Roy R; Sotgiu G; Altet-Gómez N; Tsolia M; Ruga E; Velizarova S; Kampmann B
    Am J Respir Crit Care Med; 2012 Aug; 186(4):378-84. PubMed ID: 22700862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting.
    Mandalakas AM; Kirchner HL; Walzl G; Gie RP; Schaaf HS; Cotton MF; Grewal HM; Hesseling AC
    Am J Respir Crit Care Med; 2015 Apr; 191(7):820-30. PubMed ID: 25622087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update.
    Diel R; Loddenkemper R; Niemann S; Meywald-Walter K; Nienhaus A
    Am J Respir Crit Care Med; 2011 Jan; 183(1):88-95. PubMed ID: 20802162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation.
    Moon SM; Lee SO; Choi SH; Kim YS; Woo JH; Yoon DH; Suh C; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
    Transpl Infect Dis; 2013 Feb; 15(1):104-9. PubMed ID: 22823749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test.
    Lighter J; Rigaud M; Eduardo R; Peng CH; Pollack H
    Pediatrics; 2009 Jan; 123(1):30-7. PubMed ID: 19117857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
    Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.
    Bergamini BM; Losi M; Vaienti F; D'Amico R; Meccugni B; Meacci M; De Giovanni D; Rumpianesi F; Fabbri LM; Balli F; Richeldi L
    Pediatrics; 2009 Mar; 123(3):e419-24. PubMed ID: 19254978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.